This page lists the SEC filings reported by OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC).
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2023-02-13 | UBS OCONNOR LLC | Gesher I Acquisition Corp. | 926,423 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-13 | UBS OCONNOR LLC | AfterNext HealthTech Acquisition Corp. | 1,427,113 | 5.7% | EDGAR |
| SC 13G/A | 2023-02-13 | UBS OCONNOR LLC | New Providence Acquisition Corp. II | 2,227,500 | 8.9% | EDGAR |
| SC 13G/A | 2023-02-13 | UBS OCONNOR LLC | MAGELLAN HEALTH INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-13 | UBS OCONNOR LLC | Home Plate Acquisition Corp | 1,980,000 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-13 | UBS OCONNOR LLC | SCP & CO Healthcare Acquisition Co | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-13 | UBS OCONNOR LLC | Generation Asia I Acquisition Ltd | 1,980,000 | 9.0% | EDGAR |
| SC 13G | 2023-02-13 | UBS OCONNOR LLC | Bilander Acquisition Corp. | 1,149,136 | 6.8% | EDGAR |
| SC 13G | 2023-02-13 | UBS OCONNOR LLC | DTRT Health Acquisition Corp. | 240,341 | 7.5% | EDGAR |
| SC 13G | 2023-02-13 | UBS OCONNOR LLC | Blue Apron Holdings, Inc. | 6,265,813 | 15.8% | EDGAR |
| SC 13G | 2023-02-13 | UBS OCONNOR LLC | Counter Press Acquisition Corp | 364,093 | 5.1% | EDGAR |
| SC 13G | 2023-02-13 | UBS OCONNOR LLC | Prime Impact Acquisition I | 466,683 | 6.9% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | Evolv Technologies Holdings, Inc. | 1,547,311 | 1.1% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | ACORDA THERAPEUTICS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | Jasper Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | Amryt Pharma plc | 9,950,000 | 3.1% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | Sharecare, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | GreenSky, Inc. | 698,553 | 0.8% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | GTY Technology Holdings Inc. | 758,000 | 1.3% | EDGAR |
| SC 13G/A | 2022-02-14 | UBS OCONNOR LLC | Teligent, Inc. | 0 | 0.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.